Replies to post #87556 on Amarantus Bioscience Holdings Inc (AMBS)

[blackhawks]

So if we ramp up to $3, $4, $5, $10-Mil. in sales, you can expect to see a 10 times sales, 15 times sales, or a 20 times sales buy-out of our technology"

As I said, for the short to intermediare term a JV of a grant are the likely catalysts for at least a bump in AMBS pps.

Do YOU see a 'ramp up' to those sales #'s before the end of next year or early '15? Because I don't see Gerald claiming buy-out figures based upon 'expected/hoped for sales rather than 'if we ramp up to........sales'.

[Skeetz99]

Sir Petro:

I believe you have repeatedly answered your own question (in regards to fair value). The company and mgt. have done a poor job with handling the recent financing/funding...and what confidence can you have that there wont be any more diluton (until LymPro is commercialized)?